152 related articles for article (PubMed ID: 35780831)
1. The Casein kinase 1α agonist pyrvinium attenuates Wnt-mediated CK1α degradation via interaction with the E3 ubiquitin ligase component Cereblon.
Shen C; Nayak A; Neitzel LR; Yang F; Li B; Williams CH; Hong CC; Ahmed Y; Lee E; Robbins DJ
J Biol Chem; 2022 Aug; 298(8):102227. PubMed ID: 35780831
[TBL] [Abstract][Full Text] [Related]
2. The E3 ubiquitin ligase component, Cereblon, is an evolutionarily conserved regulator of Wnt signaling.
Shen C; Nayak A; Neitzel LR; Adams AA; Silver-Isenstadt M; Sawyer LM; Benchabane H; Wang H; Bunnag N; Li B; Wynn DT; Yang F; Garcia-Contreras M; Williams CH; Dakshanamurthy S; Hong CC; Ayad NG; Capobianco AJ; Ahmed Y; Lee E; Robbins DJ
Nat Commun; 2021 Sep; 12(1):5263. PubMed ID: 34489457
[TBL] [Abstract][Full Text] [Related]
3. The CK1α Activator Pyrvinium Enhances the Catalytic Efficiency (
Shen C; Li B; Astudillo L; Deutscher MP; Cobb MH; Capobianco AJ; Lee E; Robbins DJ
Biochemistry; 2019 Dec; 58(51):5102-5106. PubMed ID: 31820934
[TBL] [Abstract][Full Text] [Related]
4. Structural basis of lenalidomide-induced CK1α degradation by the CRL4(CRBN) ubiquitin ligase.
Petzold G; Fischer ES; Thomä NH
Nature; 2016 Apr; 532(7597):127-30. PubMed ID: 26909574
[TBL] [Abstract][Full Text] [Related]
5. IMiDs induce FAM83F degradation via an interaction with CK1α to attenuate Wnt signalling.
Dunbar K; Macartney TJ; Sapkota GP
Life Sci Alliance; 2021 Feb; 4(2):. PubMed ID: 33361334
[TBL] [Abstract][Full Text] [Related]
6. Pyrvinium doubles against WNT-driven cancer.
Fan J; Reid RR; He TC
J Biol Chem; 2022 Oct; 298(10):102479. PubMed ID: 36096200
[TBL] [Abstract][Full Text] [Related]
7. Pyrvinium Sensitizes Clear Cell Renal Cell Carcinoma Response to Chemotherapy Via Casein Kinase 1α-Dependent Inhibition of Wnt/β-Catenin.
Cui L; Zhao J; Liu J
Am J Med Sci; 2018 Mar; 355(3):274-280. PubMed ID: 29549930
[TBL] [Abstract][Full Text] [Related]
8. Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α.
Thorne CA; Hanson AJ; Schneider J; Tahinci E; Orton D; Cselenyi CS; Jernigan KK; Meyers KC; Hang BI; Waterson AG; Kim K; Melancon B; Ghidu VP; Sulikowski GA; LaFleur B; Salic A; Lee LA; Miller DM; Lee E
Nat Chem Biol; 2010 Nov; 6(11):829-36. PubMed ID: 20890287
[TBL] [Abstract][Full Text] [Related]
9. Differential abundance of CK1α provides selectivity for pharmacological CK1α activators to target WNT-dependent tumors.
Li B; Orton D; Neitzel LR; Astudillo L; Shen C; Long J; Chen X; Kirkbride KC; Doundoulakis T; Guerra ML; Zaias J; Fei DL; Rodriguez-Blanco J; Thorne C; Wang Z; Jin K; Nguyen DM; Sands LR; Marchetti F; Abreu MT; Cobb MH; Capobianco AJ; Lee E; Robbins DJ
Sci Signal; 2017 Jun; 10(485):. PubMed ID: 28655862
[TBL] [Abstract][Full Text] [Related]
10. CK1α and IRF4 are essential and independent effectors of immunomodulatory drugs in primary effusion lymphoma.
Patil A; Manzano M; Gottwein E
Blood; 2018 Aug; 132(6):577-586. PubMed ID: 29954751
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Lymphoid and Myeloid Malignancies by Immunomodulatory Drugs.
Fuchs O
Cardiovasc Hematol Disord Drug Targets; 2019; 19(1):51-78. PubMed ID: 29788898
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide screen identifies cullin-RING ligase machinery required for lenalidomide-dependent CRL4
Sievers QL; Gasser JA; Cowley GS; Fischer ES; Ebert BL
Blood; 2018 Sep; 132(12):1293-1303. PubMed ID: 30042095
[TBL] [Abstract][Full Text] [Related]
13. S100A16 promotes acute kidney injury by activating HRD1-induced ubiquitination and degradation of GSK3β and CK1α.
Sun Y; Fan Y; Wang Z; Li M; Su D; Liu Y; Liang X
Cell Mol Life Sci; 2022 Mar; 79(3):184. PubMed ID: 35279748
[TBL] [Abstract][Full Text] [Related]
14. Targeting cereblon in hematologic malignancies.
Fuchs O
Blood Rev; 2023 Jan; 57():100994. PubMed ID: 35933246
[TBL] [Abstract][Full Text] [Related]
15. Pyrvinium attenuates Hedgehog signaling downstream of smoothened.
Li B; Fei DL; Flaveny CA; Dahmane N; Baubet V; Wang Z; Bai F; Pei XH; Rodriguez-Blanco J; Hang B; Orton D; Han L; Wang B; Capobianco AJ; Lee E; Robbins DJ
Cancer Res; 2014 Sep; 74(17):4811-21. PubMed ID: 24994715
[TBL] [Abstract][Full Text] [Related]
16. USP15 antagonizes CRL4
Nguyen TV
Proc Natl Acad Sci U S A; 2021 Oct; 118(40):. PubMed ID: 34583995
[TBL] [Abstract][Full Text] [Related]
17. Casein Kinase 1α as a Regulator of Wnt-Driven Cancer.
Shen C; Nayak A; Melendez RA; Wynn DT; Jackson J; Lee E; Ahmed Y; Robbins DJ
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824859
[TBL] [Abstract][Full Text] [Related]
18. Targeting the CK1α/CBX4 axis for metastasis in osteosarcoma.
Wang X; Qin G; Liang X; Wang W; Wang Z; Liao D; Zhong L; Zhang R; Zeng YX; Wu Y; Kang T
Nat Commun; 2020 Feb; 11(1):1141. PubMed ID: 32111827
[TBL] [Abstract][Full Text] [Related]
19. Role of cereblon in angiogenesis and in mediating the antiangiogenic activity of immunomodulatory drugs.
Beedie SL; Huang PA; Harris EM; Strope JD; Mahony C; Chau CH; Vargesson N; Figg WD
FASEB J; 2020 Sep; 34(9):11395-11404. PubMed ID: 32677118
[TBL] [Abstract][Full Text] [Related]
20. Pyrvinium, a potent small molecule Wnt inhibitor, promotes wound repair and post-MI cardiac remodeling.
Saraswati S; Alfaro MP; Thorne CA; Atkinson J; Lee E; Young PP
PLoS One; 2010 Nov; 5(11):e15521. PubMed ID: 21170416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
